News & AnalysisCellino rakes in $16m seedCellino, a personalized regenerative medicine company, has raised $16 million in seed funding.ByIris Dorbian2 February 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs